These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29801572)

  • 1. Pharmacoepidemiology in Pharmacogenetics.
    Ahern TP
    Adv Pharmacol; 2018; 83():109-130. PubMed ID: 29801572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods in epidemiology: observational study designs.
    DiPietro NA
    Pharmacotherapy; 2010 Oct; 30(10):973-84. PubMed ID: 20874034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiologic approach to pharmacogenomics.
    Little J; Sharp L; Khoury MJ; Bradley L; Gwinn M
    Am J Pharmacogenomics; 2005; 5(1):1-20. PubMed ID: 15727485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics and pharmacoepidemiology.
    Jones JK
    Pharmacoepidemiol Drug Saf; 2001; 10(5):457-61. PubMed ID: 11802592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of self-controlled designs in pharmacoepidemiology.
    Hallas J; Pottegård A
    J Intern Med; 2014 Jun; 275(6):581-9. PubMed ID: 24635348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interface between pharmacoepidemiology and pharmacogenetics.
    Maitland-van der Zee AH ; de Boer A ; Leufkens HG
    Eur J Pharmacol; 2000 Dec; 410(2-3):121-130. PubMed ID: 11134664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpretation of associations in pharmacoepidemiology.
    Kaufman DW
    Semin Hematol; 2008 Jul; 45(3):181-8. PubMed ID: 18582625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs.
    Etminan M; Samii A
    Pharmacotherapy; 2004 Aug; 24(8):964-9. PubMed ID: 15338844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and health services: year in review.
    Dooley MA
    Curr Opin Rheumatol; 2007 Mar; 19(2):118-21. PubMed ID: 17278925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core concepts in pharmacoepidemiology: Fundamentals of the cohort and case-control study designs.
    Pottegård A
    Pharmacoepidemiol Drug Saf; 2022 Aug; 31(8):817-826. PubMed ID: 35621007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review.
    Gault N; Castañeda-Sanabria J; De Rycke Y; Guillo S; Foulon S; Tubach F
    BMC Med Res Methodol; 2017 Feb; 17(1):25. PubMed ID: 28178924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control yourself: ISPE-endorsed guidance in the application of self-controlled study designs in pharmacoepidemiology.
    Cadarette SM; Maclure M; Delaney JAC; Whitaker HJ; Hayes KN; Wang SV; Tadrous M; Gagne JJ; Consiglio GP; Hallas J
    Pharmacoepidemiol Drug Saf; 2021 Jun; 30(6):671-684. PubMed ID: 33715267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making.
    Etminan M; Gill S; Fitzgerald M; Samii A
    J Clin Pharmacol; 2006 Jan; 46(1):6-9. PubMed ID: 16397278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating medication effects outside of clinical trials: new-user designs.
    Ray WA
    Am J Epidemiol; 2003 Nov; 158(9):915-20. PubMed ID: 14585769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of instrumental variable methods in cohort and nested case-control studies: a simulation study.
    Uddin MJ; Groenwold RH; de Boer A; Belitser SV; Roes KC; Hoes AW; Klungel OH
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):165-77. PubMed ID: 24306965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-only designs in pharmacoepidemiology: a systematic review.
    Nordmann S; Biard L; Ravaud P; Esposito-Farèse M; Tubach F
    PLoS One; 2012; 7(11):e49444. PubMed ID: 23166668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-user and prevalent-user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practices.
    Luijken K; Spekreijse JJ; van Smeden M; Gardarsdottir H; Groenwold RHH
    Pharmacoepidemiol Drug Saf; 2021 Jul; 30(7):960-974. PubMed ID: 33899305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case-crossover and case-time-control designs in pharmacoepidemiology.
    Donnan PT; Wang J
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):259-62. PubMed ID: 11501340
    [No Abstract]   [Full Text] [Related]  

  • 19. The Quasi-cohort approach in pharmacoepidemiology: upgrading the nested case-control.
    Suissa S
    Epidemiology; 2015 Mar; 26(2):242-6. PubMed ID: 25513746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them.
    Fu EL; van Diepen M; Xu Y; Trevisan M; Dekker FW; Zoccali C; Jager K; Carrero JJ
    Clin Kidney J; 2021 May; 14(5):1317-1326. PubMed ID: 33959262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.